Florastor

French Indochina (strain isolated, 1923); France (Biocodex) · 1923 · Henri Boulard (strain); Biocodex (product)

Also known as Ultra-Levure (France), Saccharomyces boulardii CNCM I-745

Maker
Biocodex
What it is
Supplement · probiotic capsule
Vehicle
Capsule · Measured oils or extracts in a capsule.
Recipe
Full recipe published: 1 botanical known
Region
France and Iberia
Watch out
Some people should avoid this · read before you try it

Sources: Biocodex (Florastor)maker

What's in it

1 confirmed by the maker.
BotanicalPartStatusSources
Saccharomyces boulardii
Saccharomyces boulardii CNCM I-745
— Confirmed

Sources: Biocodex (Florastor)maker

One active ingredient, a single named strain. The full excipient list of the US capsules couldn't be read (the site rate-limited automated requests); the French Ultra-Levure capsule's excipients are given under its variant.

Watch out

And from the botanicals inside, as noted on their own pages. Amounts in a capsule differ, but these are worth knowing:

  • Saccharomyces boulardii: AvoidRare but sometimes fatal yeast bloodstream infections (fungaemia) have been reported in critically ill or immunocompromised hospital patients taking S. boulardii, and in people with central venous catheters. France contraindicates it for all three groups, and warns that the yeast can spread on hands or through the air to nearby patients, so capsules and sachets shouldn't be opened in their rooms. A Finnish study found that at least 43% of patients with Saccharomyces fungaemia had been taking the probiotic. For: critically ill, immunocompromised, central venous catheter, people nursing them.2 more notes on its page

The evidence

LooseStudied & supportedmoderate certainty · children taking antibiotics

S. boulardii (mostly CNCM I-745) taken with antibiotics, to prevent diarrhoea

European paediatric gastroenterologists (ESPGHAN), reviewing strain-specified trials with GRADE, rated the evidence that S. boulardii prevents antibiotic-associated diarrhoea in children as moderate quality and recommended it. A 2015 meta-analysis found it cut the risk in children from about 21% to 9%.

Sources: Journal of Pediatric Gastroenterology and… 2016clinical guidelineAlimentary Pharmacology & Therapeutics 2015systematic review

LooseSome evidenceadults taking antibiotics

S. boulardii taken with antibiotics, to prevent diarrhoea

A 2015 meta-analysis of 15 trials in 3114 adults found S. boulardii cut antibiotic-associated diarrhoea from about 17% to 8%, though not C. difficile diarrhoea; its abstract doesn't give a certainty rating for adults.

Sources: Alimentary Pharmacology & Therapeutics 2015systematic review

LooseSome evidencevery low certainty · children with acute gastroenteritis

S. boulardii during acute gastroenteritis, alongside rehydration

A 2020 meta-analysis of 29 trials found children had diarrhoea for about a day less on S. boulardii, but rated the evidence low to very low quality.

Sources: Alimentary Pharmacology & Therapeutics 2020systematic review

And for saccharomyces boulardii itself

  • Saccharomyces boulardii Studied & supported for loose · S. boulardii (mostly CNCM I-745) capsules or sachets taken with antibiotics, to…